Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maurizio Affer

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of Visualized Experiments : Jove|April 24, 2023
Preparation of Cytoplasmic and Nuclear Long RNAs from Primary and Cultured CellsJacob Jahn, Sana Chaudhry, Maurizio Affer, et al.
Biomedicines|November 27, 2021
Targeted Therapies in Cancer: To Be or Not to Be, SelectiveSkye Montoya, Deborah Soong, Nina Nguyen, et al.
Blood|January 13, 2004
Inhibition of fibroblast growth factor receptor 3 induces differentiation and apoptosis in t(4;14) myelomaSuzanne Trudel, Scott Ely, Yildiz Farooqi, et al.
Protein Science : a Publication of the Protein Society|January 13, 2017
PACMANS: A bioinformatically informed algorithm to predict, design, and disrupt protease-on-protease hydrolysisMeghan C Ferrall-Fairbanks, Zachary T Barry, Maurizio Affer, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2022
A dual aurora and lim kinase inhibitor reduces glioblastoma proliferation and invasionMatthew J Rybin, Mayra Juliana Laverde-Paz, Robert K Suter, et al.
Scientific Reports|April 8, 2026
CIPHER-seq enables intracellular multimodal profiling of cytokine responses in single immune cellsAvni Bhalgat, Katarina Micin, Maurizio Affer, et al.
Leukemia|February 13, 2014
Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myelomaMaurizio Affer, Marta Chesi, Wei-Dong G Chen, et al.
Scientific Reports|April 23, 2024
RAPID resistance to BET inhibitors is mediated by FGFR1 in glioblastomaAnna M Jermakowicz, Alison M Kurimchak, Katherine J Johnson, et al.
NPJ Precision Oncology|July 2, 2025
Functional cure with single agent olutasidenib in relapsed IDH1/NPM1 co-mutated AMLJustin Watts, Tiffany Nong, Katarina Micin, et al.
Cancer Cell|February 5, 2008
AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignanciesMarta Chesi, Davide F Robbiani, Michael Sebag, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Visualized Experiments : Jove|April 24, 2023
Preparation of Cytoplasmic and Nuclear Long RNAs from Primary and Cultured CellsJacob Jahn, Sana Chaudhry, Maurizio Affer, et al.
Biomedicines|November 27, 2021
Targeted Therapies in Cancer: To Be or Not to Be, SelectiveSkye Montoya, Deborah Soong, Nina Nguyen, et al.
Blood|January 13, 2004
Inhibition of fibroblast growth factor receptor 3 induces differentiation and apoptosis in t(4;14) myelomaSuzanne Trudel, Scott Ely, Yildiz Farooqi, et al.
Protein Science : a Publication of the Protein Society|January 13, 2017
PACMANS: A bioinformatically informed algorithm to predict, design, and disrupt protease-on-protease hydrolysisMeghan C Ferrall-Fairbanks, Zachary T Barry, Maurizio Affer, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2022
A dual aurora and lim kinase inhibitor reduces glioblastoma proliferation and invasionMatthew J Rybin, Mayra Juliana Laverde-Paz, Robert K Suter, et al.
Scientific Reports|April 8, 2026
CIPHER-seq enables intracellular multimodal profiling of cytokine responses in single immune cellsAvni Bhalgat, Katarina Micin, Maurizio Affer, et al.
Leukemia|February 13, 2014
Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myelomaMaurizio Affer, Marta Chesi, Wei-Dong G Chen, et al.
Scientific Reports|April 23, 2024
RAPID resistance to BET inhibitors is mediated by FGFR1 in glioblastomaAnna M Jermakowicz, Alison M Kurimchak, Katherine J Johnson, et al.
NPJ Precision Oncology|July 2, 2025
Functional cure with single agent olutasidenib in relapsed IDH1/NPM1 co-mutated AMLJustin Watts, Tiffany Nong, Katarina Micin, et al.
Cancer Cell|February 5, 2008
AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignanciesMarta Chesi, Davide F Robbiani, Michael Sebag, et al.
Pageof 2